Fundz

Biodesix Announces Senior Secured Financing Agreement With Perceptive Advisors For Up To $50 Million

PUBLIC · BDSXNov 16, 2022

Round Type

Debt Financing

BoulderBiotechnologyHealth CareArtificial IntelligenceMedicalHealth Diagnostics

Description

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it has obtained a term loan facility for up to $50 million from Perceptive Advisors, a leading healthcare investment firm focused on supporting progress in the life sciences industry by identifying opportunities and directing financial resources toward the most promising technologies in modern healthcare. This debt capital, which is conditioned on the Company raising at least $30 million in gross proceeds through sale of its equity securities, is part of a strategic fundraising effort to strengthen the Company’s balance sheet, reduce near term cash use and enable the continued growth trajectory of the core lung diagnostics business. The proceeds from this debt offering will be used for repayment of existing debt facilities, working capital, and general corporate purposes, including expansion of the commercialization activities for the Company’s five Medicare reimbursed lung diagnostic tests.

Quick answer

BIODESIX INC raised an undisclosed amount in a Debt Financing round, dated November 16, 2022. BIODESIX INC is based in Boulder, Colorado, United States.

How much did BIODESIX INC raise?
BIODESIX INC raised an undisclosed amount in a Debt Financing round on November 16, 2022.
What does BIODESIX INC do?
Biodesix is a leading data-driven diagnostic solutions company with a focus in lung disease.
Where is BIODESIX INC based and how big is it?
BIODESIX INC is based in Boulder, Colorado, United States.

Source: Fundz verified event record.

Who else raised in Medical and Health Diagnostics around the same time

Companies in the same sectors as BIODESIX INC that raised within 45 days of this round, from Fundz verified event records.

  • Carta Healthcare raised $20M (Series B) on November 2, 2022.
  • OpenLoop raised $368K (Seed) on December 28, 2022.
  • In-Med Prognostics raised $2.1M (Seed) on December 12, 2022.
  • Perceiv AI raised an undisclosed amount on December 8, 2022.
  • Ubie raised an undisclosed amount (Series C) on December 8, 2022.
  • OpenLoop raised $13M on December 2, 2022.

Who to call at BIODESIX INC, and when

A new round usually means BIODESIX INC is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BIODESIX INC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BIODESIX INC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BIODESIX INC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BIODESIX INC

Location

2970 WILDERNESS PLACE

Boulder, Colorado, United States

About

Biodesix is a leading data-driven diagnostic solutions company with a focus in lung disease. The Company develops diagnostic tests addressing important clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers five Medicare-covered tests for patients with lung diseases. The blood based Nodify Lung® nodule risk assessment testing strategy, consisting of the Nodify XL2® and the Nodify CDT® tests, evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action. The blood based IQLung™ strategy for lung cancer patients integrates the GeneStrat® ddPCR™ test, the GeneStrat NGS™ test and the VeriStrat® test to support treatment decisions across all stages of lung cancer with results in an average of 36-72 hours, expediting time to treatment. Biodesix also leverages the proprietary and advanced Diagnostic Cortex® AI (Artificial Intelligence) platform, to collaborate with many of the world’s leading biotechnology and pharmaceutical companies to solve complex diagnostic challenges in lung disease. For more information about Biodesix, visit biodesix.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BIODESIX INC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BIODESIX INC's next move

See what Strategic adds

BIODESIX INC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.